P148 Use of micronised progesterone in women under estrogen replacement therapy: Oral vs vaginal route

Autor: Figueroa-Casas, PR, Delgado, E, Vieder, C, Rodriguez-Vidal, D

Publikováno v: Maturitas; November 1996, Vol. 27 Issue: 1-2 p89-89, 1p

A 13-month multicenter clinical experience of a low-dose monophasic oral contraceptive containing 20 microg ethinylestradiol and 75 microg gestodene in Latin American women.

Autor: Bassol S; Biomedical Research Centre University of Coahuila, Calle Gregorio A. Garcia 198 Sur, Torreon, Coahuila, Mexico. sbassol@hotmail.com, Alvarado G, Arreola RG, Celis-Gonzalez C, Peña EP, Flores JG, Ahued JR, Ricalde RL, Lopez CR, Prieto G, Gurucharri C, Heredia MG, Ortiz OC, Percossi G, Figueroa Casas PR, Botto E, Tozzini RI, Botti G, Nuñez de Pierro A, Fernandez M, Lastreto E, Nañez M, Carneiro de Oliveira H, Diogenes Holanda Yazlle ME, Silva J, Salazar G, Gomez J, Penagos G, Cifuentes R, Torres LA, Reyes-Marquez R, Albrecht G

Publikováno v: Contraception [Contraception] 2003 May; Vol. 67 (5), pp. 367-72.

Reversal by medical treatment of endometrial hyperplasia caused by estrogen replacement therapy.

Autor: Figueroa-Casas PR; Department of Gynecology, Hospital Saenz-Pena, Rosario, Argentina. pfigueroa@arnet.com.ar, Ettinger B, Delgado E, Javkin A, Vieder C

Publikováno v: Menopause (New York, N.Y.) [Menopause] 2001 Nov-Dec; Vol. 8 (6), pp. 420-3.

[Cutaneous viral diseases. Its treatment by using photodynamic inactivation].

Autor: Lurati CE, Romano Boix E, Figueroa Casas PR

Publikováno v: Medicina cutanea ibero-latino-americana [Med Cutan Ibero Lat Am] 1974; Vol. 2 (6), pp. 459-69.

[Clinical results with hypothalamic gonadotropin releasing hormone (LH-RH) and the treatment of anovulatory sterility].

Autor: Figueroa Casas PR, Badano AR, Aparicio NJ, Miechi H, Mirkin A, Bicocca C

Publikováno v: Obstetricia y ginecologia latino-americanas [Obstet Ginecol Lat Am] 1974 Jul-Aug; Vol. 32 (7-8), pp. 257-63.